US Stock MarketDetailed Quotes
HOOK HOOKIPA Pharma
- 2.480
- +0.160+6.90%
Close Nov 27 16:00 ET
- 2.480
- 0.0000.00%
Post 16:00 ET
24.54MMarket Cap-675P/E (TTM)
2.500High2.331Low62.76KVolume2.390Open2.320Pre Close153.72KTurnover1.31%Turnover RatioLossP/E (Static)9.89MShares11.30052wk High0.34P/B11.88MFloat Cap2.08052wk Low--Dividend TTM4.79MShs Float200.000Historical High--Div YieldTTM7.29%Amplitude2.080Historical Low2.449Avg Price1Lot Size
HOOKIPA Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 27.41%-17.51M | 25.64%-14.38M | -748.17%-24.16M | -187.66%-57.52M | -185.44%-11.22M | -46.10%-24.12M | -5.31%-19.33M | -264.34%-2.85M | 69.71%-20M | 199.20%13.14M |
| Net income from continuing operations | 27.40%-13.84M | -5.99%-19.1M | 173.08%14.38M | -25.67%-81.58M | -101.59%-24.82M | -4.30%-19.07M | -10.15%-18.02M | -9.53%-19.68M | 14.21%-64.92M | 42.02%-12.31M |
| Depreciation and amortization | 43.74%700K | -17.55%714K | -30.51%640K | -1.39%3.55M | 41.37%1.28M | -35.92%487K | 0.70%866K | -14.56%921K | -22.37%3.6M | -26.38%904K |
| Other non cash items | ---- | ---- | ---- | -60.00%64K | -65.12%60K | --0 | --0 | -94.59%4K | -86.95%160K | -85.57%172K |
| Change In working capital | 10.35%-5.48M | 223.17%3.55M | -355.30%-38.93M | -85.24%5.33M | -103.97%-927K | -4,467.14%-6.11M | 33.45%-2.88M | -9.92%15.25M | 1,035.33%36.11M | 515.84%23.37M |
| -Change in receivables | 52.42%-1.56M | 502.60%8.22M | -396.55%-11.68M | 250.24%3.45M | 308.66%4.84M | -77.95%-3.29M | 20.02%-2.04M | -10.93%3.94M | -2.73%-2.3M | -77.85%-2.32M |
| -Change in prepaid assets | 38.06%4.4M | -3,497.78%-3.24M | 143.73%992K | -13.55%1.74M | -771.21%-1.77M | 161.48%3.19M | 61.37%-90K | -46.16%407K | 128.30%2.01M | -79.38%264K |
| -Change in payables and accrued expense | -1,015.15%-2.11M | -136.72%-527K | -133.94%-1.52M | 1,267.71%6.99M | 201.22%833K | -91.95%231K | 1,921.13%1.44M | 379.75%4.49M | -90.93%511K | -328.65%-823K |
| -Change in other current assets | ---- | ---- | 56.54%-93K | -28.30%304K | 215.61%546K | ---- | ---- | 53.48%-214K | 1.92%424K | -79.72%173K |
| -Change in other current liabilities | -744.23%-335K | -537.35%-529K | 43.49%-330K | 3,007.89%1.11M | 92.61%1.72M | 116.99%52K | 73.57%-83K | -87.78%-584K | 98.10%-38K | 515.35%893K |
| -Change in other working capital | 100.46%28K | 79.69%-470K | -464.62%-26.3M | -123.26%-8.26M | -128.18%-7.1M | -224.06%-6.06M | -19.59%-2.31M | -48.95%7.21M | 2,397.05%35.51M | 646.44%25.19M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 27.41%-17.51M | 25.64%-14.38M | -748.17%-24.16M | -187.66%-57.52M | -185.44%-11.22M | -46.10%-24.12M | -5.31%-19.33M | -264.34%-2.85M | 69.71%-20M | 199.20%13.14M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 98.97%-31K | 89.89%-45K | 57.66%-116K | 17.10%-4.16M | 29.55%-422K | -215.03%-3.02M | 72.73%-445K | 85.01%-274K | 60.12%-5.02M | 88.35%-599K |
| Net PPE purchase and sale | 98.97%-31K | 89.89%-45K | 57.66%-116K | 17.10%-4.16M | 29.55%-422K | -215.03%-3.02M | 72.73%-445K | 85.01%-274K | 60.12%-5.02M | 88.35%-599K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 98.97%-31K | 89.89%-45K | 57.66%-116K | 17.10%-4.16M | 29.55%-422K | -215.03%-3.02M | 72.73%-445K | 85.01%-274K | 60.12%-5.02M | 88.35%-599K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -102.49%-1.14M | 81.63%-135K | -9.13%65.67M | 10,941.33%21.25M | -618.90%-659K | 1,651.47%45.82M | -100.98%-735K | 30,853.62%72.27M | 52.20%-196K |
| Net issuance payments of debt | --0 | 1.38%-1.14M | --0 | 38.46%-1.75M | --0 | --0 | 60.83%-1.16M | -2,885.00%-597K | -550.68%-2.85M | 99.73%-1K |
| Net common stock issuance | --0 | --0 | --0 | 7.34%49.04M | --21.25M | -19,850.00%-395K | 2,818,700.00%28.19M | -100.00%1K | 22,407.88%45.69M | --0 |
| Net preferred stock issuance | --0 | ---- | ---- | -37.45%18.53M | --0 | ---263K | ---- | ---- | --29.63M | --0 |
| Net other financing activities | --0 | --0 | 2.88%-135K | 23.59%-149K | --0 | ---1K | ---9K | ---139K | ---195K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -102.49%-1.14M | 81.63%-135K | -9.13%65.67M | 10,941.33%21.25M | -618.90%-659K | 1,651.47%45.82M | -100.98%-735K | 30,853.62%72.27M | 52.20%-196K |
| Net cash flow | ||||||||||
| Beginning cash position | -43.13%77.35M | -15.51%92.96M | 3.59%117.52M | 69.54%113.44M | 7.37%108.1M | 14.43%136.01M | -22.41%110.02M | 69.54%113.44M | -53.27%66.91M | 21.74%100.68M |
| Current changes in cash | 36.90%-17.54M | -159.77%-15.56M | -532.80%-24.41M | -91.56%3.99M | -22.19%9.6M | -60.31%-27.8M | 213.48%26.04M | -105.13%-3.86M | 159.95%47.26M | 165.67%12.34M |
| Effect of exchange rate changes | 221.19%143K | 18.37%-40K | -136.64%-159K | 112.41%90K | -141.55%-177K | 86.02%-118K | ---49K | 241.37%434K | -128.24%-725K | -85.84%426K |
| End cash Position | -44.53%59.96M | -43.13%77.35M | -15.51%92.96M | 3.59%117.52M | 3.59%117.52M | 7.37%108.1M | 14.43%136.01M | -22.41%110.02M | 69.54%113.44M | 69.54%113.44M |
| Free cash flow | 35.37%-17.54M | 27.09%-14.42M | -677.45%-24.27M | -146.59%-61.68M | -192.89%-11.65M | -55.37%-27.14M | 1.07%-19.78M | -3,186.32%-3.12M | 68.17%-25.01M | 168.20%12.54M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data